Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Perion Network Announces Conference Participation in November - December 2024
-
Enveda Announces First Candidate Discovered From Nature Using AI Advances to Clinical Trials
-
First Anti-Aging and Wellness Relive Health Clinic opens in Charlotte, SouthPark.
-
Kennametal Named Among Top of Caterpillar Inc's 2024 Indirect Suppliers
-
CyberArk Announces Strong Third Quarter 2024 Results
-
Sound Point Meridian Capital, Inc. Announces Results for the Second Fiscal Quarter Ended September 30, 2024
-
Forsea Achieves Record-Breaking Cell Density for Its Cultivated Seafood
-
Caesarstone Reports Third Quarter 2024 Financial Results
-
Breckenridge Distillery's Latest Creation is the Perfect Addition to Your Holiday Bar: Breckenridge Candy Cane Vodka
-
UL Solutions Announces Quarterly Dividend
-
Veritone Achieves AWS Media and Entertainment Services Competency
-
kWh Analytics Receives ‘Go’ Decision from U.S. Department of Energy for phase two of PV Reliability Award
-
Harrow Launches Access and Affordability Program with Price Reductions for Branded Products
-
Augurex and New Day Diagnostics Announce Launch of Anti-14-3-3eta Multiplex Analyte Specific Reagents; Enabling a First-In-Class Diagnostic Test for Axial Spondyloarthritis
-
TRexBio Announces $84 Million Series B Financing to Advance Pipeline of First-in-Class Immunology Programs into Clinical Development
-
Genomic Testing Cooperative Unveils “GTC Interpret,” a Groundbreaking Web-Based Platform for Partner Labs to Access Analyzed Sequencing Data and Finalize Reports
-
Patterson Dental Extends Strategic Relationship With PDS Health
-
MindMed to Participate in Upcoming Investor Conferences
-
I Squared Capital Appoints Patricia Menéndez Cambó as General Counsel
-
Healx announces agreement with Sanofi to seek new rare disease indications for compound using AI drug discovery platform
-
Metsera Secures $215 Million Series B Financing to Further Accelerate Portfolio
-
Air Industries Group Announces Earnings Release Date
-
Reverb Therapeutics to Collaborate With Royalmount Laboratories on Development of Advanced Bispecific Antibodies
-
Acurx Pharmaceuticals, Inc. Reports Third Quarter 2024 Results and Provides Business Update
-
Assisted Living/Memory Care Senior Living Communities See Stronger Family Member Satisfaction Since Pandemic, J.D. Power Finds
-
STAAR Surgical to Participate in Stephens Annual Investment Conference (NASH2024)
-
Vergent LMS Launches OmniaText: Transforming Communications for Lenders
-
Business Leaders and Industry Experts Join Top Policymakers to Address Pivotal Issues in Health Globally at the Milken Institute 2024 Future of Health Summit
-
Renowned Chef Eric Crowley Announces the Closure of Chef Eric's Culinary Classroom After 22 Memorable Years
-
Innoviz Reports Third Quarter 2024 Results
-
Coterra Announces Accretive Permian Basin Acquisitions
-
Adroit DI Unveils Transformative Chemistry & Biology Data Platform at Breakthrough $10/Month Pricing
-
Arizona Soccer Association Partners with Stack Team App to Drive Participation Growth and Engagement
-
Halifax Group Invests in Universal Air Conditioner
-
McDermott Awarded Harriet Alpha Decommissioning Contract by Santos
-
Sun Life hosts Investor Day 2024 in Toronto
-
Siyata Mobile Products Deployed by EMS Organization in Papua New Guinea
-
Beamr Issues Q3-2024 CEO Letter to Shareholders: Focus on Marketing Strategies and Building the Sales Funnel
-
BioRestorative Therapies Reports Positive Preliminary Phase 2 BRTX-100 Clinical Data
-
PolyPid Provides Corporate Update and Reports Third Quarter 2024 Financial Results
-
Jade Biosciences to Participate in Upcoming Investor Conferences
-
Accelsius Secures $24M in Series A Funding to Efficiently Cool AI Data Centers
-
Plug Power Hosts 2024 Plug Symposium
-
GigaCloud Technology Inc Welcomes Industry Veteran Marshall Bernes to Board
-
Instil Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update
-
Entero Therapeutics Announces Proposed Reverse Merger with Journey Therapeutics, A Clinical Stage, First-in-Class, Next-Generation ADC-rivalling Nano-immunoconjugates Biopharmaceutical Company
-
Bitfarms Reports Third Quarter 2024 Results
-
Wag! Reports Third Quarter 2024 Results
-
Osisko Development Reports Third Quarter 2024 Results
-
Venus Concept Announces Third Quarter of Fiscal Year 2024 Financial Results

